Health Policy Monitor, Pharmaceutical Price Policy

Hofmarcher, Maria M. and Röhrling, Gerald (2003) Health Policy Monitor, Pharmaceutical Price Policy. Bertelsmann Stiftung, Health Policy Monitor 2003 (2), 7 p.

oa42.pdf - Published Version

Download (36kB) | Preview


The two main reasons for a future cost increase in the pharmaceutical sector in Austria are the demographic development and medical progress.In order to contain cost increases the policy purses two objectives: Introduction of a new price formation procedure and increased generic consumption to 20% of all prescribed drugs by 2006.

Item Type: Discussion/ Working Paper (Unspecified)
Keywords: Pharmaceutical Policy
Date Deposited: 06 Oct 2016 09:53
Last Modified: 23 Feb 2017 12:25

Actions (login required)

View Item View Item